As genetic testing is an area with implications extending far beyond that of the primary patient, it is appropriately an area that is under increased scrutiny.
To ensure that high quality is maintained in the delivery of genetic services, several agencies have developed standards and guidelines.
The present article summarises important recommendations made by the American College of Medical Genetics (ACMG), the College of American Pathologists (CAP), the US Health Care Financing Administration (HCFA), and the US Food and Drug Administration (FDA) as they relate to genetic testing.
Some of the standards are based on voluntary compliance, whereas others have the force of regulation.
They all address issues of personnel credentials, laboratory operations, and the most critical quality assurance and control measures for diagnostic laboratories from the perspective of various agencies.
In most instances, the standards promulgated by these agencies are offered as minimum criteria.
The exact impact of these regulations on the practice of medical genetics has yet to be established.
Mots-clés Pascal : Laboratoire, Génétique, Biologie clinique, Recommandation, Pratique professionnelle, Assurance qualité, Norme, Diagnostic, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Laboratory, Genetics, Clinical biology, Recommendation, Professional practice, Quality assurance, Standards, Diagnosis, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0553884
Code Inist : 002B23A. Création : 01/03/1996.